Join us and your life science colleagues for an open, engaging and informative discussion around the best ways for small life science companies to raise capital to generate big value.
This is part two of a collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. An interactive event based on dialogue and networking.
Moderator is Björn Stansvik, CEO, Mentormate, who is also giving a speech on ”Digital & Personal Connected Health”.
15:00-15:30: Coffee and registration
15:30-15:45: Welcome and introduction
Charlotta Gummeson, CEO, Sahlgrenska Science Park
15:45-16:10: Digital & Personal Connected Health
Björn Stansvik, Moderator for the day and CEO/Founder, MentorMate
16:10-16:35: Sustainable financing to complement equity
Karin Reuterskiöld, Sustainable Business Strategist, Danske Bank
16:35-17:00: Is IPO still an attractive alternative for capitalizing a life science company?
Jacob Gunterberg, Partner, HealthCap
17:00-17:25: News for listed companies
Jakob Kaule, Head of Surveillance, Nasdaq Copenhagen
17:25-17:35: Nasdaq Bell Closing
Niclas Holmberg, Managing Director Global Listing Services, Nasdaq
17:35-18:05: Panel discussion: Title TBD
– Nicholas Waters, CEO, IRLAB Therapeutics AB
– Magnus Björsne, CEO, AstraZeneca BioVentureHub
– Karin Reuterskiöld
– Charlotta Gummeson
– Jacob Gunterberg
– Niclas Holmberg
· Moderator asks individualized questions to each panelist in turn (shorter answers)
· Interweaved with questions from audience
18:05-18:10: Closing Remarks
18:10-19:00: Networking, Drinks/buffet food served